Review



sid 26681509  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress sid 26681509
    Sid 26681509, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sid 26681509/product/MedChemExpress
    Average 94 stars, based on 7 article reviews
    sid 26681509 - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    MedChemExpress sid 26681509
    Sid 26681509, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sid 26681509/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    sid 26681509 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    99
    MedChemExpress sid26681509 medchemexpress cat
    Sid26681509 Medchemexpress Cat, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sid26681509 medchemexpress cat/product/MedChemExpress
    Average 99 stars, based on 1 article reviews
    sid26681509 medchemexpress cat - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    94
    MedChemExpress sid26681509
    Pharmacological inhibition of CTSL attenuates LPS-induced inflammatory response and ALI (A) BMDM were stimulated with LPS (100 ng/mL), or treated with <t>SID26681509</t> (5 μM) for 6 h. Cells were then harvested to analyze secreted IL-6, CXCL1, and CXCL2 proteins in cell culture supernatants using ELISA, n = 3 each group. (B) HBE were stimulated with LPS (100 μg/mL) or treated with SID26681509 (1 μM) for 24 h. Cells were then harvested for analyzing secreted IL-6 and IL-8 proteins in cell culture supernatants using ELISA, n = 3 each group. (C) THP-1 were stimulated with LPS (100 ng/mL), or treated with SID26681509 (5 μM) for 6 h, Cells were then harvested for analyzing secreted IL-6, IL-8 proteins in cell culture supernatants using ELISA, n = 3 each group. (D) Mice were treated by intraperitoneal injection with SID26681509 (20 mg/kg) 1h before pentobarbital injection and then with LPS (in 50 μL saline) at a dose of 5 mg/kg or NS though intratracheal administration. Mice were sacrificed 24 h after LPS administration for analysis. Total and differential cell counts in the BALF from mice, n (DMSO) = 3, n (LPS) = 5, n (SID26681509) = 3, and n (SID26681509 + LPS) = 5. (E) Total protein concentration in the BALF. (F) Expression of IL6, CXCL1, and CXCL2 in the BALF. (G) Representative images of lung tissue with HE staining 24 h post-LPS challenge and histological inflammatory scores. Scale bar: 200μm. (H) For the survival assay, mice were treated intratracheally administered LPS (20 mg/kg) on day 0. Mice received an intraperitoneal injection of SID26681509 (20 mg/kg) or PBS 1 h before intratracheal instillation on day 0 and were injected with the drugs twice on day 3. Survival rates of mice after the intratracheal administration of LPS with or without IAAP intraperitoneal injection for 24 h. n (DMSO + LPS) = 17, n (SID26681509 + LPS) = 13. DMSO was used as the vehicle control. All the quantitative data are presented as mean ± SEM and differences were identified using one-way ANOVA. The log rank (Mantel-Cox) test was used to analyze survival rates. ∗ p < 0.05, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001.
    Sid26681509, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sid26681509/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    sid26681509 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress cathepsin l inhibitor sid 26681509
    Pharmacological inhibition of CTSL attenuates LPS-induced inflammatory response and ALI (A) BMDM were stimulated with LPS (100 ng/mL), or treated with <t>SID26681509</t> (5 μM) for 6 h. Cells were then harvested to analyze secreted IL-6, CXCL1, and CXCL2 proteins in cell culture supernatants using ELISA, n = 3 each group. (B) HBE were stimulated with LPS (100 μg/mL) or treated with SID26681509 (1 μM) for 24 h. Cells were then harvested for analyzing secreted IL-6 and IL-8 proteins in cell culture supernatants using ELISA, n = 3 each group. (C) THP-1 were stimulated with LPS (100 ng/mL), or treated with SID26681509 (5 μM) for 6 h, Cells were then harvested for analyzing secreted IL-6, IL-8 proteins in cell culture supernatants using ELISA, n = 3 each group. (D) Mice were treated by intraperitoneal injection with SID26681509 (20 mg/kg) 1h before pentobarbital injection and then with LPS (in 50 μL saline) at a dose of 5 mg/kg or NS though intratracheal administration. Mice were sacrificed 24 h after LPS administration for analysis. Total and differential cell counts in the BALF from mice, n (DMSO) = 3, n (LPS) = 5, n (SID26681509) = 3, and n (SID26681509 + LPS) = 5. (E) Total protein concentration in the BALF. (F) Expression of IL6, CXCL1, and CXCL2 in the BALF. (G) Representative images of lung tissue with HE staining 24 h post-LPS challenge and histological inflammatory scores. Scale bar: 200μm. (H) For the survival assay, mice were treated intratracheally administered LPS (20 mg/kg) on day 0. Mice received an intraperitoneal injection of SID26681509 (20 mg/kg) or PBS 1 h before intratracheal instillation on day 0 and were injected with the drugs twice on day 3. Survival rates of mice after the intratracheal administration of LPS with or without IAAP intraperitoneal injection for 24 h. n (DMSO + LPS) = 17, n (SID26681509 + LPS) = 13. DMSO was used as the vehicle control. All the quantitative data are presented as mean ± SEM and differences were identified using one-way ANOVA. The log rank (Mantel-Cox) test was used to analyze survival rates. ∗ p < 0.05, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001.
    Cathepsin L Inhibitor Sid 26681509, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cathepsin l inhibitor sid 26681509/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    cathepsin l inhibitor sid 26681509 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    Pharmacological inhibition of CTSL attenuates LPS-induced inflammatory response and ALI (A) BMDM were stimulated with LPS (100 ng/mL), or treated with SID26681509 (5 μM) for 6 h. Cells were then harvested to analyze secreted IL-6, CXCL1, and CXCL2 proteins in cell culture supernatants using ELISA, n = 3 each group. (B) HBE were stimulated with LPS (100 μg/mL) or treated with SID26681509 (1 μM) for 24 h. Cells were then harvested for analyzing secreted IL-6 and IL-8 proteins in cell culture supernatants using ELISA, n = 3 each group. (C) THP-1 were stimulated with LPS (100 ng/mL), or treated with SID26681509 (5 μM) for 6 h, Cells were then harvested for analyzing secreted IL-6, IL-8 proteins in cell culture supernatants using ELISA, n = 3 each group. (D) Mice were treated by intraperitoneal injection with SID26681509 (20 mg/kg) 1h before pentobarbital injection and then with LPS (in 50 μL saline) at a dose of 5 mg/kg or NS though intratracheal administration. Mice were sacrificed 24 h after LPS administration for analysis. Total and differential cell counts in the BALF from mice, n (DMSO) = 3, n (LPS) = 5, n (SID26681509) = 3, and n (SID26681509 + LPS) = 5. (E) Total protein concentration in the BALF. (F) Expression of IL6, CXCL1, and CXCL2 in the BALF. (G) Representative images of lung tissue with HE staining 24 h post-LPS challenge and histological inflammatory scores. Scale bar: 200μm. (H) For the survival assay, mice were treated intratracheally administered LPS (20 mg/kg) on day 0. Mice received an intraperitoneal injection of SID26681509 (20 mg/kg) or PBS 1 h before intratracheal instillation on day 0 and were injected with the drugs twice on day 3. Survival rates of mice after the intratracheal administration of LPS with or without IAAP intraperitoneal injection for 24 h. n (DMSO + LPS) = 17, n (SID26681509 + LPS) = 13. DMSO was used as the vehicle control. All the quantitative data are presented as mean ± SEM and differences were identified using one-way ANOVA. The log rank (Mantel-Cox) test was used to analyze survival rates. ∗ p < 0.05, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001.

    Journal: iScience

    Article Title: Inhibition of cathepsin L ameliorates inflammation through the A20/NF-κB pathway in endotoxin-induced acute lung injury

    doi: 10.1016/j.isci.2024.111024

    Figure Lengend Snippet: Pharmacological inhibition of CTSL attenuates LPS-induced inflammatory response and ALI (A) BMDM were stimulated with LPS (100 ng/mL), or treated with SID26681509 (5 μM) for 6 h. Cells were then harvested to analyze secreted IL-6, CXCL1, and CXCL2 proteins in cell culture supernatants using ELISA, n = 3 each group. (B) HBE were stimulated with LPS (100 μg/mL) or treated with SID26681509 (1 μM) for 24 h. Cells were then harvested for analyzing secreted IL-6 and IL-8 proteins in cell culture supernatants using ELISA, n = 3 each group. (C) THP-1 were stimulated with LPS (100 ng/mL), or treated with SID26681509 (5 μM) for 6 h, Cells were then harvested for analyzing secreted IL-6, IL-8 proteins in cell culture supernatants using ELISA, n = 3 each group. (D) Mice were treated by intraperitoneal injection with SID26681509 (20 mg/kg) 1h before pentobarbital injection and then with LPS (in 50 μL saline) at a dose of 5 mg/kg or NS though intratracheal administration. Mice were sacrificed 24 h after LPS administration for analysis. Total and differential cell counts in the BALF from mice, n (DMSO) = 3, n (LPS) = 5, n (SID26681509) = 3, and n (SID26681509 + LPS) = 5. (E) Total protein concentration in the BALF. (F) Expression of IL6, CXCL1, and CXCL2 in the BALF. (G) Representative images of lung tissue with HE staining 24 h post-LPS challenge and histological inflammatory scores. Scale bar: 200μm. (H) For the survival assay, mice were treated intratracheally administered LPS (20 mg/kg) on day 0. Mice received an intraperitoneal injection of SID26681509 (20 mg/kg) or PBS 1 h before intratracheal instillation on day 0 and were injected with the drugs twice on day 3. Survival rates of mice after the intratracheal administration of LPS with or without IAAP intraperitoneal injection for 24 h. n (DMSO + LPS) = 17, n (SID26681509 + LPS) = 13. DMSO was used as the vehicle control. All the quantitative data are presented as mean ± SEM and differences were identified using one-way ANOVA. The log rank (Mantel-Cox) test was used to analyze survival rates. ∗ p < 0.05, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001.

    Article Snippet: SID26681509 , MedChemExpress , Cat#HY-103353.

    Techniques: Inhibition, Cell Culture, Enzyme-linked Immunosorbent Assay, Injection, Saline, Protein Concentration, Expressing, Staining, Clonogenic Cell Survival Assay, Control

    CTSL regulates the LPS-induced K63-linked polyUb binding of NEMO by degrading A20 (A) BMDM cells were treated with IAAP or SID26681509 for 6 h, then stimulated with LPS (100 ng/mL) for 5 min, the levels of p -IKKα/β, IκBα, p -IκBα, p65, p-p65, and ACTB were examined using Western blotting. (B) BMDM cells were treated with IAAP or SID26681509 for 6 h, then stimulated with LPS (100 ng/mL) for 5 min. BMDM was analyzed for the spatial approximation of IKKγ with K63-linked polyUb components using PLA. Red, proximity ligation-positive signals. Scale bars: 5 μm. The quantification shown on the right represents the fluorescence, n = 15. (C) BMDM cells were treated with IAAP or SID26681509 for 6 h, then stimulated with LPS (100 ng/mL) for 5 min, the levels of A20, NEMO, IKKβ, and ACTB were examined using Western blotting. (D) BMDM cells were analyzed for the spatial approximation of A20 with CTSL components using PLA. Red, proximity ligation-positive signals. Scale bars: 5 μm. Quantification shown on the right represents the fluorescence, n = 15. (E) BMDM cells were transfected with control-, A20 -siRNA for 24 h. Then cells were treated with IAAP (5 μM) or SID26681509 (5 μM) for 6 h, and then stimulated with LPS (100 ng/mL) for 5 min. Cells were then harvested for analyzing the mRNA expression of IL-6 and CXCL1 using qRT-PCR, n = 3 in each group. DMSO was used as the vehicle control. All the quantitative data are presented as mean ± SEM and differences were identified using one-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001; ns, p > 0.05.

    Journal: iScience

    Article Title: Inhibition of cathepsin L ameliorates inflammation through the A20/NF-κB pathway in endotoxin-induced acute lung injury

    doi: 10.1016/j.isci.2024.111024

    Figure Lengend Snippet: CTSL regulates the LPS-induced K63-linked polyUb binding of NEMO by degrading A20 (A) BMDM cells were treated with IAAP or SID26681509 for 6 h, then stimulated with LPS (100 ng/mL) for 5 min, the levels of p -IKKα/β, IκBα, p -IκBα, p65, p-p65, and ACTB were examined using Western blotting. (B) BMDM cells were treated with IAAP or SID26681509 for 6 h, then stimulated with LPS (100 ng/mL) for 5 min. BMDM was analyzed for the spatial approximation of IKKγ with K63-linked polyUb components using PLA. Red, proximity ligation-positive signals. Scale bars: 5 μm. The quantification shown on the right represents the fluorescence, n = 15. (C) BMDM cells were treated with IAAP or SID26681509 for 6 h, then stimulated with LPS (100 ng/mL) for 5 min, the levels of A20, NEMO, IKKβ, and ACTB were examined using Western blotting. (D) BMDM cells were analyzed for the spatial approximation of A20 with CTSL components using PLA. Red, proximity ligation-positive signals. Scale bars: 5 μm. Quantification shown on the right represents the fluorescence, n = 15. (E) BMDM cells were transfected with control-, A20 -siRNA for 24 h. Then cells were treated with IAAP (5 μM) or SID26681509 (5 μM) for 6 h, and then stimulated with LPS (100 ng/mL) for 5 min. Cells were then harvested for analyzing the mRNA expression of IL-6 and CXCL1 using qRT-PCR, n = 3 in each group. DMSO was used as the vehicle control. All the quantitative data are presented as mean ± SEM and differences were identified using one-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001; ns, p > 0.05.

    Article Snippet: SID26681509 , MedChemExpress , Cat#HY-103353.

    Techniques: Binding Assay, Western Blot, Ligation, Fluorescence, Transfection, Control, Expressing, Quantitative RT-PCR

    Journal: iScience

    Article Title: Inhibition of cathepsin L ameliorates inflammation through the A20/NF-κB pathway in endotoxin-induced acute lung injury

    doi: 10.1016/j.isci.2024.111024

    Figure Lengend Snippet:

    Article Snippet: SID26681509 , MedChemExpress , Cat#HY-103353.

    Techniques: Recombinant, Magnetic Beads, Transfection, BIA-KA, Activity Assay, In Situ, Enzyme-linked Immunosorbent Assay, Control, Software